1. Home
  2. ASMB vs VGI Comparison

ASMB vs VGI Comparison

Compare ASMB & VGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Assembly Biosciences Inc.

ASMB

Assembly Biosciences Inc.

HOLD

Current Price

$31.40

Market Cap

553.6M

Sector

Health Care

ML Signal

HOLD

Logo Virtus Global Multi-Sector Income Fund of Beneficial Interest

VGI

Virtus Global Multi-Sector Income Fund of Beneficial Interest

HOLD

Current Price

$7.89

Market Cap

88.4M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
ASMB
VGI
Founded
2005
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Investment Managers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
553.6M
88.4M
IPO Year
2010
N/A

Fundamental Metrics

Financial Performance
Metric
ASMB
VGI
Price
$31.40
$7.89
Analyst Decision
Strong Buy
Analyst Count
6
0
Target Price
$43.40
N/A
AVG Volume (30 Days)
154.0K
46.0K
Earning Date
11-10-2025
01-01-0001
Dividend Yield
N/A
12.66%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$37,191,000.00
N/A
Revenue This Year
$33.33
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
31.30
N/A
52 Week Low
$7.75
$6.68
52 Week High
$39.71
$7.99

Technical Indicators

Market Signals
Indicator
ASMB
VGI
Relative Strength Index (RSI) 40.89 59.44
Support Level $31.73 $7.82
Resistance Level $34.69 $7.94
Average True Range (ATR) 2.09 0.06
MACD -0.40 0.01
Stochastic Oscillator 9.66 73.28

Price Performance

Historical Comparison
ASMB
VGI

About ASMB Assembly Biosciences Inc.

Assembly Biosciences Inc is a clinical-stage biotechnology company. It is advancing two platform programs, a novel class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics, which are designed to restore health to a dysbiotic microbiome. The company's HBV-cure program is aimed at increasing the current low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. Assembly has discovered several novel core protein Allosteric Modulators, which are small molecules that directly target and allosterically modulate the HBV core protein. The majority of the revenue is generated from the HBV cure program.

About VGI Virtus Global Multi-Sector Income Fund of Beneficial Interest

Virtus Global Multi-Sector Inc is a United States based fund. Its investment objective is to maximize current income while preserving capital. The Fund seeks to achieve its investment objective by applying extensive credit research to capitalize on opportunities across undervalued areas of the international bond markets.

Share on Social Networks: